These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24520755)

  • 1. Frequency of prediabetes in women with polycystic ovary syndrome.
    Ibricevic D; Asimi ZV
    Med Arch; 2013; 67(4):282-5. PubMed ID: 24520755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome.
    Godinjak A; Godinjak Z; Burekovic A; Surkovic I; Dizdarevic-Bostandzic A; Velija-Asimi Z
    Med Arch; 2012; 66(6):409-11. PubMed ID: 23409523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
    Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.
    Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G
    Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
    Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
    Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S; Mollabashi M; Kerman SR
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
    Pelanis R; Mellembakken JR; Sundström-Poromaa I; Ravn P; Morin-Papunen L; Tapanainen JS; Piltonen T; Puurunen J; Hirschberg AL; Fedorcsak P; Andersen M; Glintborg D
    Hum Reprod; 2017 Nov; 32(11):2279-2286. PubMed ID: 29040530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.
    Reyes-Muñoz E; Ortega-González C; Martínez-Cruz N; Arce-Sánchez L; Estrada-Gutierrez G; Moran C; Sánchez-Serrano AP; Higareda-Sánchez R; de la Jara-Díaz JF
    BMJ Open; 2016 Jul; 6(7):e012107. PubMed ID: 27449893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
    Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
    Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls.
    Huddleston HG; Quinn MM; Kao CN; Lenhart N; Rosen MP; Cedars MI
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):775-782. PubMed ID: 29044581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.
    Dejager S; Pichard C; Giral P; Bruckert E; Federspield MC; Beucler I; Turpin G
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):455-62. PubMed ID: 11318780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome.
    Cenk Sayin N; Gücer F; Balkanli-Kaplan P; Ali Yüce M; Yardim T
    Gynecol Endocrinol; 2003 Oct; 17(5):387-96. PubMed ID: 14710586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.